2016-03-05T00:00:00.000-05:00
health system leader,0.559497
special focus,0.733014
market expansion,0.492992
new CLL patients,-0.356831
bigger market,0.29701
FiercePharma,0.477045
chronic lymphocytic leukemia,-0.504977
New standout Imbruvica,0.492992
market development,0.733014
JNJ,0.304216
health systems,0.546987
orphan drugs,-0.261916
Evercore ISI analyst,-0.231104
first-line nod,-0.504977
pharma industry leaders,0.485023
CLL patients,-0.356831
Phase III trial,-0.539843
Mark Schoenebaum,-0.231104
standout cancer,-0.43243
multiple myeloma,-0.525707
companies,0.537291
disease progression,-0.539843
B-cell malignancies,-0.525707
Johnson,0.332432
pharmaceutical company news,0.733014
daily email,0.485023
Special Report,0.310967
new reimbursement models,0.546987
daily monitor,0.469067
FDA,0.228037
Illinois pharma,-0.373216
chemo treatment chlorambucil,-0.539843
